In 1999, the Inter-agency Working Group on Reproductive Health in Crises, hereafter the IAWG, wrote the Minimum Initial Services Package, hereafter MISP, which is the second chapter in Reproductive Health in Refugee Situations: An Inter-agency Field Manual. The IAWG wrote MISP for governments and agencies, who respond to humanitarian crises, as a guide for the provision of reproductive health services at the beginning of a humanitarian crises. The goal of MISP was to outline the services that people in humanitarian crises are to receive to minimize injury and death from complications related to reproductive health, prevent and manage the consequences of sexual violence, and reduce the transmission of sexually transmitted infections, or STIs. MISP recognizes that reproductive health is a human right and applies to people in humanitarian crises, providing specific details for governments and agencies to follow and mitigate the adverse effects of reproductive health issues in vulnerable populations.

Emmett McLoughlin wrote People's Padre: An Autobiography, based on his experiences as a Roman Catholic priest advocating for the health of people in Arizona. The Beacon Press in Boston, Massachusetts, published the autobiography in 1954. McLoughlin was a Franciscan Order Roman Catholic priest who advocated for public housing and healthcare for the poor and for minority groups in Phoenix, Arizona, during the mid twentieth century. The autobiography recounts McLoughlin's efforts in founding several community initiatives throughout Phoenix, including the St. Monica's Community Center, later renamed St. Pius X Catholic Church, the Phoenix housing projects, and St. Monica's Hospital, later renamed Phoenix Memorial Hospital. McLoughlin's autobiography discusses his advocacy for people to have greater access to maternity and prenatal healthcare, to testing and treatment for sexually transmitted infections, and to birth control in the Phoenix area.

Mary Ware Dennett, an activist in the US for birth control and sex education in the early twentieth century, wrote an educational pamphlet in 1915 called “The Sex Side of Life, and it was published in 1919. The pamphlet defined the functions of the sex organs, emphasized the role of love and pleasure in sex, and described other sexual processes of the body not usually discussed openly. In the early twentieth century in the US, individuals did not have wide access to sex education due to the limitations enforced by the Comstock Act, which prohibited the distribution and discussion of topics that were considered obscene. In 1929, the US tried Dennett for mailing her pamphlet as a violation of the Comstock Act, sending obscene material through the United States Postal Service. Dennett’s pamphlet, Tthe “Sex Side of Life,” and her subsequent trial, United States v. Dennett, contributed to a national discussion about sex education and human reproduction and led to the revision of reproduction- related obscenity laws.

In 2011, United Kingdom pharmaceutical company GlaxoSmithKline released Cervarix, a vaccination series protecting girls and women from two strains of Human Papillomavirus, or HPV. HPV, a sexually transmitted infection, can present in men and women without symptoms, or may cause symptoms such as genital warts. There is a link between HPV and cervical, vaginal, anal, head, neck, and face cancers, and Cervarix can reduce genital cancers in girls and women, particularly cervical cancer. Gardasil, a similar vaccination against HPV, approved by the United States Food and Drug Administration, or FDA and available in the US in June 2006 was on the market five years prior to Cervarix’s approval in October 2009. In 2014, because of the heightened cost and lesser coverage, the US market discontinued Cervarix, but as of 2019, it remains popular in Europe, especially in the United Kingdom. Cervarix is the first HPV vaccine administered in China.

Gonorrhea is a sexually transmitted disease, or STD, caused by the bacterium Neisseria gonorrhoeae. Common symptoms of the disease include painful urination and genital discharge. There are records of historical discussions of gonorrhea in ancient civilizations and during the Middle Ages, but scientists did not begin investigating the scientific causes and treatments of the STD until the sixteenth century. In the 1700s, physicians attributed gonorrhea to the same cause as another STD, syphilis. Later, in the 1800s, researchers discovered the two diseases were not the same and identified the bacteria N. gonorrhoeae that causes gonorrhea. By the 1900s, researchers began using antibiotics to target the bacteria, but many drugs eventually developed antibiotic resistance. In 2020, the World Health Organization, or WHO, estimated that 82.4 million individuals contracted gonorrhea globally, and as of 2024, researchers continue to experiment with various antibiotic drugs to provide adequate treatment for the disease.

In 1944, Joseph Earl Moore and colleagues published “The Treatment of Early Syphilis with Penicillin: A Preliminary Report of 1418 Cases,” hereafter “Treatment of Early Syphilis,” in the Journal of the American Medical Association. Moore and colleagues’ article was one of the first to study and explore the use of penicillin, an antibiotic that can kill bacteria, as a treatment for humans with syphilis, which is a bacterial disease that spreads through sexual contact. In its early stages, syphilis can cause rashes and genital sores, but in its late stages, it can also lead to organ damage. In “Treatment of Early Syphilis,” Moore and his colleagues explain that they conducted a study to determine the effects and optimal dose of penicillin in humans with early syphilis. The authors found that giving individuals with syphilis specific doses of penicillin can heal their syphilitic lesions and eradicate the bacterium that causes syphilis from their bodies. “Treatment of Early Syphilis” was one of the first articles to demonstrate that syphilis, specifically early syphilis, could be effectively treated with penicillin, the drug that physicians still most commonly use as of 2024 to treat the sexually transmitted disease.

In July 2011, Makoto Ohnishi and colleagues published the article “Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone,” hereafter, “Untreatable Gonorrhea,” in the journal Antimicrobial Agents and Chemotherapy. Gonorrhea is a sexually transmitted disease, or STD, caused by the bacterium Neisseria gonorrhoeae. In 2009, Ohnishi and a few of his co-authors found the first ceftriaxone-resistant strain of gonorrhea, called H041. That strain demonstrated resistance to ceftriaxone, one of the last remaining and effective first-line antibiotic treatment drugs for N. gonorrhoeae. In “Untreatable Gonorrhea,” Ohnishi and Colleagues confirm that the H041 strain is resistant to ceftriaxone and analyze the bacterium’s mechanism of resistance. “Untreatable Gonorrhea” was one of the first publications to characterize the H041strain and highlights a need for global public health interventions to prevent the rapid spread of gonorrhea.

Philippe Ricord was a nineteenth-century physician and surgeon in France who studied syphilis and demonstrated that it is different from gonorrhea. As of 2024, researchers recognize that syphilis and gonorrhea are both sexually transmitted infections, or STIs. However, the bacterium Treponema pallidum causes syphilis, leading to symptoms such as sores and fever, whereas the bacterium Neisseria gonorrhoeae causes gonorrhea and leads to different symptoms such as discharge from the urethra. Before Ricord, researchers thought syphilis and gonorrhea were the same disease. Ricord, through observation and experimentation, distinguished syphilis from gonorrhea and arranged the stages of syphilis into primary, secondary, and tertiary, each associated with different symptoms and levels of severity. By distinguishing syphilis from other STDs and accurately categorizing its stages, Ricord helped researchers better understand how to treat syphilis, a disease that can be transmitted from mother to child, causing life-threatening illness in infants.